Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
[Editorial] journalArticle 2018 Perrier, L.
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort journalArticle 2018 Kandel, M.; Allayous, C.; Dalle, S.; Mortier, L.; Dalac, S.; Dutriaux, C.; Leccia, M. T.; Guillot, B.; Saiag, P.; Lacour, J. P.; Legoupil, D.; Lesimple, T.; Aubin, F.; Beylot-Barry, M.; Brunet-Possenti, F.; Arnault, J. P.; Granel-Brocard, F.; Stoebner, P. E.; Dupuy, A.; Maubec, E.; Grob, J. J.; Dreno, B.; Rotolo, F.; Ballon, A.; Michiels, S.; Lebbe, C.; Borget, I.
Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma journalArticle 2018 Brodowicz, T.; Mir, O.; Wallet, J.; Italiano, A.; Blay, J. Y.; Bertucci, F.; Eisterer, W.; Chevreau, C.; Piperno-Neumann, S.; Bompas, E.; Ryckewaert, T.; Liegl-Antzwager, B.; Thery, J.; Penel, N.; Le Cesne, A.; Le Deley, M. C.
Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome journalArticle 2018 Randon, M.; Lévy-Gabriel, C.; Abbas, R.; Dendale, R.; Lumbroso, L.; Desjardins, L.; Cassoux, N.
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study journalArticle 2018 Gaspar, N.; Occean, B. V.; Pacquement, H.; Bompas, E.; Bouvier, C.; Brisse, H. J.; Castex, M. P.; Cheurfa, N.; Corradini, N.; Delaye, J.; Entz-Werle, N.; Gentet, J. C.; Italiano, A.; Lervat, C.; Marec-Berard, P.; Mascard, E.; Redini, F.; Saumet, L.; Schmitt, C.; Tabone, M. D.; Verite-Goulard, C.; Le Deley, M. C.; Piperno-Neumann, S.; Brugieres, L.; Sfce; Gsf, Geto; group, Unicancer sarcoma
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study journalArticle 2018 Blanchard, P.; Pugh, T. J.; Swanson, D. A.; Mahmood, U.; Chen, H. C.; Wang, X.; Graber, W. J.; Kudchadker, R. J.; Bruno, T.; Feeley, T.; Frank, S. J.
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study journalArticle 2018 Fresneau, B.; Orbach, D.; Faure-Conter, C.; Sudour-Bonnange, H.; Vérité, C.; Gandemer, V.; Pasquet, M.; Fasola, S.; Rome, A.; Raimbault, S.; Martelli, H.; Frappaz, D.; Le Teuff, G.; Patte, C.
[Economic analysis of multinational clinical trials in oncology] journalArticle 2018 Lejeune, C.; Lueza, B.; Bonastre, J.
Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation journalArticle 2018 Frank, S. J.; Blanchard, P.; Lee, J. J.; Sturgis, E. M.; Kies, M. S.; Machtay, M.; Vikram, B.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Hutcheson, K.; Lai, S.; Busse, P. M.; Lee, N. Y.; Lin, A.; Foote, R. L.
What''s next in using CT scans to better understand cachexia? journalArticle 2018 Antoun, S.; Rossoni, C.; Lanoy, E.
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer journalArticle 2018 Seymour, L.; Le Teuff, G.; Brambilla, E.; Shepherd, F. A.; Soria, J. C.; Kratzke, R.; Graziano, S.; Douillard, J. Y.; Rosell, R.; Reiman, A.; Lacas, B.; Lueza, B.; Aviel-Ronen, S.; McLeer, A.; Le Chevalier, T.; Pirker, R.; Filipits, M.; Dunant, A.; Pignon, J. P.; Tsao, M. S.; Committee, L. ACE-Bio Steering
[Data sources, the data used, and the modality for collection] journalArticle 2018 Mercier, G.; Costa, N.; Dutot, C.; Riche, V. P.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer journalArticle 2018 Criscitiello, C.; Bayar, M. A.; Curigliano, G.; Symmans, F. W.; Desmedt, C.; Bonnefoi, H.; Sinn, B.; Pruneri, G.; Vicier, C.; Pierga, J. Y.; Denkert, C.; Loibl, S.; Sotiriou, C.; Michiels, S.; André, F.
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer journalArticle 2018 Rotolo, F.; Zhu, C. Q.; Brambilla, E.; Graziano, S. L.; Olaussen, K.; Le-Chevalier, T.; Pignon, J. P.; Kratzke, R.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Michiels, S.; Tsao, M. S.
Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT journalArticle 2018 Mohamed, A. S. R.; Bahig, H.; Aristophanous, M.; Blanchard, P.; Kamal, M.; Ding, Y.; Cardenas, C. E.; Brock, K. K.; Lai, S. Y.; Hutcheson, K. A.; Phan, J.; Wang, J.; Ibbott, G.; Gabr, R. E.; Narayana, P. A.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Group, M. D. Anderson MRLinac Development Working
Revisiting vascular contraindications for transoral robotic surgery for oropharyngeal cancer journalArticle 2018 Gorphe, P.; Auperin, A.; Honart, J. F.; Ton Van, J.; El Bedoui, S.; Bidault, F.; Temam, S.; Kolb, F.; Qassemyar, Q.
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference journalArticle 2018 Nicolai, N.; Biasoni, D.; Catanzaro, M. A.; Colecchia, M.; Trama, A.
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors journalArticle 2018 Guerrero-Zotano, A.; Stricker, T.; Formisano, L.; Hutchinson, K. E.; Stover, D. G.; Lee, K. M.; Schwarz, L. J.; Giltnane, J. M.; Estrada, M. V.; Jansen, V. M.; Servetto, A.; Gavilá, J.; Pérez-Fidalgo, J. A.; Lluch, A.; Llombart-Cussac, A.; Bayar, M. A.; Michiels, S.; Andre, F.; Arnedos, M.; Guillem, V.; Ruiz-Simon, A.; Arteaga, C. L.
A benchmark study of scoring methods for non-coding mutations journalArticle 2018 Drubay, D.; Gautheret, D.; Michiels, S.
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial journalArticle 2018 Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D.
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial journalArticle 2018 Tao, Y.; Auperin, A.; Sire, C.; Martin, L.; Khoury, C.; Maingon, P.; Bardet, E.; Kaminsky, M. C.; Lapeyre, M.; Chatellier, T.; Alfonsi, M.; Pointreau, Y.; Jadaud, E.; Géry, B.; Zawadi, A.; Tourani, J. M.; Laguerre, B.; Coutte, A.; Racadot, S.; Hasbini, A.; Malaurie, E.; Borel, C.; Meert, N.; Cornely, A.; Ollivier, N.; Casiraghi, O.; Sun, X. S.; Bourhis, J.
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting journalArticle 2018 Imbimbo, M.; Maury, J. M.; Garassino, M.; Girard, N.
Phase I–II trial designs: how early should efficacy guide the dose recommendation process? journalArticle 2018 Paoletti, X; Postel-Vinay, S
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas journalArticle 2018 Delahousse, J.; Verlingue, L.; Broutin, S.; Legoupil, C.; Touat, M.; Doucet, L.; Ammari, S.; Lacroix, L.; Ducreux, M.; Scoazec, J. Y.; Malka, D.; Paci, A.; Hollebecque, A.
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score journalArticle 2019 Simon, M.; Bosset, P. O.; Rouanne, M.; Benhamou, S.; Radulescu, C.; Molinie, V.; Neuzillet, Y.; Paoletti, X.; Lebret, T.
Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer journalArticle 2019 Elhammali, A.; Blanchard, P.; Yoder, A.; Liao, Z.; Zhang, X.; Ronald Zhu, X.; Allen, P. K.; Jeter, M.; Welsh, J.; Nguyen, Q. N.
[Post-treatment follow-up of head and neck cancer patients] journalArticle 2019 Graff, P.; Blanchard, P.; Thariat, J.; Racadot, S.; Lapeyre, M.
The association between coffee consumption and bladder cancer in the bladder cancer epidemiology and nutritional determinants (BLEND) international pooled study journalArticle 2019 Yu, E. Y.; Wesselius, A.; van Osch, F.; Stern, M. C.; Jiang, X.; Kellen, E.; Lu, C. M.; Pohlabeln, H.; Steineck, G.; Marshall, J.; Allam, M. F.; La Vecchia, C.; Johnson, K. C.; Benhamou, S.; Zhang, Z. F.; Bosetti, C.; Taylor, J. A.; Zeegers, M. P.
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer journalArticle 2019 Kothari, G.; Ost, P.; Cheung, P.; Blanchard, P.; Tree, A. C.; van As, N. J.; Lo, S. S.; Moghanaki, D.; Loblaw, A.; Siva, S.
Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma journalArticle 2019 Limkin, E. J.; Blanchard, P.
Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei journalArticle 2019 Benhaim, L.; Faron, M.; Gelli, M.; Sourrouille, I.; Honore, C.; Delhorme, J. B.; Elias, D.; Goere, D.
A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland journalArticle 2019 Schaffar, R.; Bouchardy, C.; Chappuis, P. O.; Bodmer, A.; Benhamou, S.; Rapiti, E.
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] journalArticle 2019 Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F.
GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol journalArticle 2019 Pasquier, D.; Le Deley, M. C.; Tresch, E.; Cormier, L.; Duterque, M.; Nenan, S.; Lartigau, E.
Compartmental resection of a retroperitoneal sarcoma journalArticle 2019 Faron, M.; Cavalcanti, A.; Honore, C.
Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort journalArticle 2019 Taban, F.; Elia, N.; Rapiti, E.; Rageth, C.; Fioretta, G.; Benhamou, S.; Than Lam, G.; David-Montefiore, E.; Bouchardy, C.
Nasopharyngeal carcinoma journalArticle 2019 Chen, Y. P.; Chan, A. T. C.; Le, Q. T.; Blanchard, P.; Sun, Y.; Ma, J.
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] journalArticle 2019 Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F.
Post Radiation Grade 3 neuroendocrine carcinoma (PRNEC): a new entity? journalArticle 2019 Hadoux, J.; Blanchard, P.; Scoazec, J. Y.; Burtin, P.; Planchard, D.; Malka, D.; Berdelou, A.; Boige, V.; Duvillard, P.; Leboulleux, S.; Faron, M.; Tselikas, L.; Deutsch, E.; Ducreux, M.; Baudin, E.
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach journalArticle 2019 Laas, E.; Hamy, A. S.; Michel, A. S.; Panchbhaya, N.; Faron, M.; Lam, T.; Carrez, S.; Pierga, J. Y.; Rouzier, R.; Lerebours, F.; Feron, J. G.; Reyal, F.